Emerging Trends in Etomidate and Xylazine: Wastewater‐Based Monitoring Reveals the First Detection of Etomidate in Australia

The emergence of non-opioid adulterants in illicit opioid products has increased the complexity and health risks associated with illicit drug markets worldwide. Although xylazine has become a recognised adulterant within illicit opioid markets, etomidate has emerged as a novel adulterant in the fentanyl supply and illicit electronic cigarette (vape) products. Wastewater-based epidemiology provides a population-level surveillance approach capable of detecting emerging psychoactive substances before they are recognised through conventional monitoring systems. This study reports the first detection of etomidate in Australian wastewater and examines temporal and spatial trends in etomidate and xylazine over a one-year period. A total of 936 influent wastewater samples were analysed across seven collection periods between April 2025 and April 2026 from metropolitan and regional catchments throughout Australia. Xylazine was detected in 188 samples and etomidate in 183 samples. Xylazine was widely distributed across Australia but declined steadily throughout the study, with detection frequency decreasing from 41% to 5%. In contrast, etomidate detections increased from 28% to 43% across major cities and expanded into regional areas during the latter stages of monitoring. These wastewater findings provided early evidence of etomidate's emergence in Australia, preceding subsequent reports through other surveillance systems. The contrasting trends are consistent with international reports describing a shift from xylazine towards alternative veterinary sedatives, including etomidate and the emergence of etomidate in electronic cigarettes. These findings demonstrate the value of national wastewater surveillance programs for monitoring changes in illicit drug markets and informing timely public health and harm reduction responses.

Authors

Institutions

Publication Details

Journal
Drug Testing and Analysis
Published
2026-11-18
DOI
https://doi.org/10.1002/dta.70198
Primary Topic
Forensic Toxicology and Drug Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Emerging Trends in Etomidate and Xylazine: Wastewater‐Based Monitoring Reveals the First Detection of Etomidate in Australia

Brock Peake, Bradley S. Simpson, Cobus Gerber, Emma L Keller et al.
Drug Testing and Analysis
Forensic Toxicology and Drug Analysis
article

Emerging Trends in Etomidate and Xylazine: Wastewater‐Based Monitoring Reveals the First Detection of Etomidate in Australia

Brock Peake, Bradley S. Simpson, Cobus Gerber, Emma L Keller, Emma Barber
article en

Abstract

The emergence of non-opioid adulterants in illicit opioid products has increased the complexity and health risks associated with illicit drug markets worldwide. Although xylazine has become a recognised adulterant within illicit opioid markets, etomidate has emerged as a novel adulterant in the fentanyl supply and illicit electronic cigarette (vape) products. Wastewater-based epidemiology provides a population-level surveillance approach capable of detecting emerging psychoactive substances before they are recognised through conventional monitoring systems. This study reports the first detection of etomidate in Australian wastewater and examines temporal and spatial trends in etomidate and xylazine over a one-year period. A total of 936 influent wastewater samples were analysed across seven collection periods between April 2025 and April 2026 from metropolitan and regional catchments throughout Australia. Xylazine was detected in 188 samples and etomidate in 183 samples. Xylazine was widely distributed across Australia but declined steadily throughout the study, with detection frequency decreasing from 41% to 5%. In contrast, etomidate detections increased from 28% to 43% across major cities and expanded into regional areas during the latter stages of monitoring. These wastewater findings provided early evidence of etomidate's emergence in Australia, preceding subsequent reports through other surveillance systems. The contrasting trends are consistent with international reports describing a shift from xylazine towards alternative veterinary sedatives, including etomidate and the emergence of etomidate in electronic cigarettes. These findings demonstrate the value of national wastewater surveillance programs for monitoring changes in illicit drug markets and informing timely public health and harm reduction responses.

Drug Testing and Analysis
Adelaide University (AU), The University of Adelaide (AU)
Forensic Toxicology and Drug Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon